Posted on 12/11/20
Dr. Matthew Kalady Joins Activ Surgical Advisory Board
Activ Surgical, a digital surgery pioneer, today announced that Dr. Matthew Kalady, Chief of the Colon and Rectal Surgery Division at the Ohio State University College . . .
Posted on 12/11/20
Rhythm Pharmaceuticals Appoints Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors
Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases
Posted on 12/10/20
J. Michael McQuade Elected to Albany International Corp. Board
Albany International Corp. (NYSE:AIN) announced today that J. Michael McQuade, Ph.D. has been elected to its Board of Directors.
Posted on 12/10/20
NeurAegis Announces Formation of Scientific-Medical Advisory Board
NeurAegis, Inc., a neuropharmaceutical company developing breakthrough treatments for neurological disorders, today announced the inaugural members of its Scientific-Medical Advisory Board
Posted on 12/10/20
Silicon Therapeutics Announces Members of Scientific Advisory Board
BOSTON--(BUSINESS WIRE)--Silicon Therapeutics, a privately-held, integrated therapeutics company with a pioneering drug discovery platform based on physics-driven molecular simulations, today announced the members of the Silicon . . .
Posted on 12/10/20
Waters Corporation Appoints Pearl S. Huang to Board of Directors
Waters Corporation (NYSE:WAT) today announced that Dr. Pearl S. Huang, President and CEO of Cygnal Therapeutics and venture partner at Flagship Pioneering,
Posted on 12/9/20
Eric Schadt Founder & CEO of Sema4 Named 2020 BioCT Entrepreneur of the Year
NEW HAVEN, Conn.--(BUSINESS WIRE)--Eric Schadt, Ph.D., the Founder and CEO of Sema4, a patient-centered health intelligence company, has been named the 2020 BioCT Entrepreneur of the . . .
Posted on 12/9/20
Cognito Therapeutics Appoints Brent Vaughan as Chief Executive Officer
Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders including Alzheimer’s disease
Posted on 12/9/20
Progress CEO Yogesh Gupta Elected Co-Chair of MassTLC Board of Trustees
Progress (NASDAQ: PRGS), the leading provider of products to develop, deploy and manage high-impact business applications, today announced that CEO Yogesh Gupta
Posted on 12/9/20
Synlogic Appoints Michael Heffernan to Board
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointment of Michael Heffernan to its . . .
Posted on 12/9/20
Cerevance Appoints David Lubner to Board of Directors
Cerevance, a private drug discovery and development company focused on brain diseases, today announced the appointment of David Lubner
Posted on 12/8/20
Watts Water Technologies Elects Michael Dubose to Its Board of Directors
Watts Water Technologies, Inc. (NYSE: WTS) today announced the election of Michael J. Dubose as a member of the Board of Directors.
Posted on 12/8/20
Mike Relich Joins Newmine Advisory Board
Newmine, a leader in product returns reduction technology and developers of Chief Returns Officer® announced today that Mike Relich, Interim CEO of PacSun Eddie Bauer has . . .
Posted on 12/8/20
Plymouth Rock Home Assurance Appoints Julie Rochman to its Board of Directors
Plymouth Rock Home Assurance Corporation, the home insurance business of Plymouth Rock Assurance, today announced the appointment of Julie Rochman to its Board of Directors.
Posted on 12/8/20
Candel Therapeutics Appoints Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer
NEEDHAM, Mass.--(BUSINESS WIRE)--Candel Therapeutics today announced that Paul-Peter Tak, M.D., Ph.D., was appointed president and chief executive officer of Candel Therapeutics in a planned transition to lead . . .
Posted on 12/8/20
Five Star Senior Living CEO Katie Potter Named a Top Senior Housing Influencer by GlobeSt. Real Estate Forum
Five Star Senior Living Inc. (Nasdaq: FVE) is pleased to announce that Katie Potter, president and chief executive officer, has been recognized as a Senior Housing . . .
Posted on 12/8/20
Cognex Appoints Sachin Lawande CEO
Cognex Corporation (NASDAQ: CGNX) today announced the appointment of Sachin S. Lawande, President and Chief Executive
Posted on 12/7/20
Stealth BioTherapeutics Appoints Eve E. Slater, M.D., F.A.C.C. to Board
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction
Posted on 12/7/20
Alcresta Therapeutics Appoints Alan Muney, MD To Board
Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, today announced the appointment of Alan Muney, MD to its Board . . .
Posted on 12/7/20
TransAct Technologies Announces Retirement of Thomas R. Schwarz from its Board
HAMDEN, Conn.--(BUSINESS WIRE)--TransAct Technologies Incorporated (Nasdaq: TACT), a global leader in software-driven technology and printing solutions for high-growth markets, today announced that Director Thomas R. Schwarz . . .
Posted on 12/7/20
Leigh-Ann Larson to Assume Role of CEO of Elevate Counseling Services
Elevate Counseling Services, a growing practice serving the needs of clients from locations in South Easton, Middleboro and Bellingham
Posted on 12/4/20
Palleon Pharmaceuticals Appoints Deepa Pakianathan, Ph.D., to Board
Palleon Pharmaceuticals, a company pioneering the field of glycan-mediated immune regulation to treat cancer and inflammatory diseases, today announced the appointment of Deepa Pakianathan, Ph.D., as . . .
Posted on 12/4/20
Morphic Therapeutic Appoints Dr. Martin W. Edwards to Board
Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced the appointment of Dr. Martin W. Edwards, to its Board of Directors.
Posted on 12/4/20
North Attleboro Businessman David Santoro Re-elected to Board of Directors for Financial Planning Association of Massachusetts
North Attleboro resident David Santoro, a principal in the firm Santoro Financial Planning Group, has been re-elected
Posted on 12/3/20
Karuna Therapeutics Appoints David Wheadon, M.D., to Board
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with . . .
Boston
